CPSC2013-01-31
Triaminic and Theraflu Products Recalled Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning
Novartis Consumer Health Inc., of Parsippany, NJ
Hazard
These child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place, posing a risk of unintentional ingestion and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Remedy
Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.
Sold at
Food, drug, mass merchandise and club stores nationwide between May 2010 and December 2011 for about $5.
Affected count
About 2.3 Million
Injuries reported
The firm has received 12 reports of children unscrewing the locked caps, including four reports of children ingesting the product. One child required medical attention.
Manufactured in
United States
Remedy type
Refund
Products
Triaminic® Syrups and Theraflu Warming Relief® Syrups
Consumer contact
Novartis Consumer Healthcare toll-free at (866) 553-6742 from 8 a.m. to midnight ET, Monday through Saturday, or online at www.novartisOTC.com for more information.
Official notice
https://www.cpsc.gov/Recalls/2013/Triaminic-and-Theraflu-Products-RecalledDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief